Jonathan Sims

Jonathan Sims Email and Phone Number

Senior Director at Eli Lilly and Company @ Eli Lilly and Company
Jonathan Sims's Location
Indianapolis, Indiana, United States, United States
Jonathan Sims's Contact Details

Jonathan Sims personal email

Jonathan Sims phone numbers

About Jonathan Sims

Jonathan Sims is a Senior Director at Eli Lilly and Company at Eli Lilly and Company. He possess expertise in cell culture, cell, pcr, flow cytometry, immunology and 22 more skills. Colleagues describe him as "Jonathan joined my lab as an undergraduate researcher in August, 2003. I was very pleased with his maturity and his performance during his time at Western Kentucky University. Jonathan was polite, and he had a good attitude. During his time in my lab, I observed Jonathan’s strong work ethic. He was reliable and he worked well independently. These qualities are cherished by faculty who sponsor undergraduate workers. My lab studies bacterial viruses and Jonathan assisted in the characterization of Salmonella specific bacteriophages from swine manure lagoons. Jonathan was always willing to learn new techniques and to optimize protocols. His project involved the isolation of phage plaques, the growth of high titer stocks, the purification of the phage particles by cesium chloride centrifugation and the preparation of samples for electron microscopy (EM). Jonathan’s EM pictures were very good. They were presented at scientific conferences and published in the Journal of Environmental Quality (2006). Jonathan was one of the most hard working and dependable undergraduates who have worked my lab."

Jonathan Sims's Current Company Details
Eli Lilly and Company

Eli Lilly And Company

View
Senior Director at Eli Lilly and Company
Jonathan Sims Work Experience Details
  • Eli Lilly And Company
    Senior Director
    Eli Lilly And Company Oct 2024 - Present
    Indianapolis, Indiana, Us
  • Eli Lilly And Company
    Director
    Eli Lilly And Company Mar 2022 - Oct 2024
    Indianapolis, Indiana, Us
    1. Laquer V, Parra V, Lacour JP, Takahashi H, Knorr J, Okragly AJ, James DE, Sims JT, Chang CY, Chao J, Klekotka P. (2022) IL-33 antibody failed to demonstrate benefit in a phase 2 double-blind, randomised placebo-controlled study in adult patients with moderate-to-severe atopic dermatitis. Br J Dermatol. 2022 Apr 28. https://doi.org/10.1111/bjd.216312. Dörner T, Tanaka Y, Dow ER, Koch AE, Silk M, Ross Terres JA, Sims JT, Sun Z, de la Torre I, Petri M. (2022) Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus. Ann Rheum Dis. 2022 May 24:annrheumdis-2022-222335. https://doi.org/10.1136/annrheumdis-2022-2223353. Sims JT, Chang CY, Poorbaugh J, Daniels M, Beasley SL, Zhang L, Rodgers GH, Lena F, Lacerenza LG, Sposato B, Dupont A, Susen S, Casalini G, Corbellino M, Stebbing J, Krishnan V. (2022) Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients. J Transl Med. 2022 Sep 8;20(1):411. https://doi.org/10.1186/s12967-022-03583-54. Parthasarathy V, Cravero K, Deng J, Sun Z, Engle SM, Auxier AN, Hahn N, Sims JT, Okragly AJ, Alphonse MP, Kwatra SG. (2022) Circulating plasma IL-13 and periostin are dysregulated type 2 inflammatory biomarkers in prurigo nodularis: A cluster analysis. Front Med (Lausanne). 2022 Dec 6;9:1011142. https://doi.org/10.3389/fmed.2022.10111425. Ju T, Labib A, Nattkemper L, Engle S, Auxier A, Hahn N, Sissons S, Sims JT, Sun Z, Okragly AJ, Yosipovitch G. (2023) Serum Interleukin-13 and Caspase 8 are Elevated in Prurigo Nodularis. Acta Derm Venereol. 2023 Feb 7;103:adv00861. https://doi.org/10.2340/actadv.v103.4804
  • Eli Lilly And Company
    Principal Research Scientist
    Eli Lilly And Company Oct 2021 - Mar 2022
    Indianapolis, Indiana, Us
    1. Zhou, J., Gemperline, D.C., Turner, M.J., Oldach, J., Molignano, J., Sims, J.T., Stayrook, K.R. (2021) Transcriptomic Analysis of Healthy and Atopic Dermatitis Samples Reveals the Role of IL-37 in Human Skin. ImmunoHorizons. 2021 Oct 26;5(10):830-843. https://doi.org/10.4049/immunohorizons.21000552. Engle, S.M., Chang, C.Y., Ulrich, B.J., Satterwhite, A., Hayes, T., Robling, K., Sissons, S.E., Schmitz, J., Tepper, R.S., Kaplan, M.H., Sims, J.T. (2021) Predictive biomarker modeling of pediatric atopic dermatitis severity based on longitudinal serum collections. Clinical & Experimental Immunology. Nov 30, 2021; uxab009, https://doi.org/10.1093/cei/uxab009.3. Sims JT, Poorbaugh J, Chang CY, Holzer TR, Zhang L, Engle SM, Beasley S, Doman TN, Naughton L, Higgs RE, Kallewaard N, Benschop RJ. (2022) Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab. J Transl Med. 2022 Mar 18;20(1):134. https://doi.org/10.1186/s12967-022-03345-3
  • Eli Lilly And Company
    Senior Research Scientist
    Eli Lilly And Company Oct 2019 - Sep 2021
    Indianapolis, Indiana, Us
    1. Sims, JT, Krishnan, V, Chang, CY, Engle, SM, Casalini, G, Rodgers, GH, Nickoloff, BJ, Konrad, RJ, de Bono, S, Higgs, RE, Benschop, RJ, Ottaviani, S, Cardoso, A, Nirula, A, Corbellino, M, Stebbing, J (2020) Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19. J Allergy Clin Immunol. Sep 10 https://doi.org/10.1016/j.jaci.2020.08.0312. Sims, J.T., Chang, C.Y., Higgs, R.E., Liu, Y., Engle, S.M., Sissons, S.E., Rodgers, G.H., Simpson, E.L., Silverberg, J.I., Forman, S.B., Janes J.M., Colvin, S.C., Guttman-Yassky, E. (2021) Insights into adult atopic dermatitis heterogeneity derived from circulating biomarker profiling in patients with moderate-to-severe disease. Experimental Dermatology. 18 May https://doi.org/10.1111/exd.14389
  • Eli Lilly And Company
    Research Scientist
    Eli Lilly And Company Dec 2013 - Sep 2019
    Indianapolis, Indiana, Us
  • Eli Lilly And Company
    Post Doctoral Scientist
    Eli Lilly And Company Aug 2012 - Nov 2013
    Indianapolis, Indiana, Us
    Joint research position with the Biological Mass Spectrometry and Autoimmunity groups in the Tailored Therapeutics division of LRL. My work focused on the phosphoproteomic analysis of cytokine signaling pathways.
  • University Of Kentucky
    Graduate Student In Molecular & Biomedical Pharmacology Department
    University Of Kentucky Aug 2006 - Apr 2012
    Lexington, Ky, Us
    I studied the role of the Abelson family (c-Abl, Arg) non-receptor tyrosine kinases in breast cancer and melanoma progression in order to devise new therapeutic strategies for the treatment of highly metastatic forms of disease. ------1. Srinivasan, D., Sims, J.T., Plattner R. (2008) Deregulated Abl Kinases Promote Proliferation, Anchorage-Independent Growth and Survival of Aggressive Breast Cancer Cells. Oncogene, 14;27(8):1095-105. 2. Sims, J.T., and R. Plattner. (2009) MTT assays cannot be utilized to study the effects of STI571/Gleevec on the viability of solid tumor cell lines. Cancer Chemotherapy and Pharmacology, Aug;64(3):629-33. 3. Sims, J.T., Ganguly, S., Fiore, L, Holler, C., Park, E.S., Plattner, R. (2009) STI571 (Gleevec) sensitizes breast cancer cells to 5-Fluorouracil, Cisplatin, and Camptothecin in a cell type-specific manner. Biochemical Pharmacology, Aug 1;78(3):249-60.4. Zhao, H., Ou-Yang, F., Chen I., Hou, M., Yuan, S.F., Chang, H., Lee, Y., Plattner R., Waltz, S., Ho, S., Sims, J., Wang, S. (2010) Enhanced resistance to tamoxifen by the c-ABL proto-oncogene in breast cancer. Neoplasia, Mar;12(3):214-23.5. Ganguly, S., Fiore L.S., Sims, J.T., Friend, J.W., Srinivasan, D., Cibull, M.L., Wang, C., Novak, M., Kaetzel, D.M., Plattner, R. (2011) c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression. Oncogene, Sep 5.6. Sims JT, Ganguly SS, Bennett H, Friend JW, Tepe J, Plattner R. (2013) Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1. PLoS One. 2013;8(1):e55509.
  • University Of Kentucky
    Research Assistant In Microbiology, Immunology, & Molecular Genetics Department
    University Of Kentucky Jan 2005 - Aug 2005
    Lexington, Ky, Us
    Studied the binding properties of Anaplasma phagocytophilum that promote infection of human neutrophils using a variety of molecular and microbiological techniques, cell culture, flow cytometry, and IFA. ------1. Reneer, D.V., Kearns, S.A., Yago, T., Sims, J., Cummings, R.D., McEver, R.P., Carlyon, J.A. (2006) Characterization of a sialic acid- and P-selectin glycoprotein ligand-1-independent adhesin activity in the granulocytotropic bacterium Anaplasma phagocytophilum. Cellular Microbiology, Dec;8(12):1972-842. Huang, B., Troese, M.J., Ye, S., Sims, J.T., Galloway, N.L., Borjesson, D., Carlyon, J.A. (2010) Anaplasma phagocytophilum APH1387 is expressed throughout bacterial intracellular development and localizes to the pathogen-occupied vacuolar membrane. Infect Immun, May;78(5):1864-73.3. Huang, B., Troese, M.J., Howe, D., Ye, S., Sims, J.T., Heinzen,R., Borjesson, D., Carlyon, J.A. (2010) Anaplasma phagocytophilum APH_0032 is expressed late during infection and localizes to the pathogen-occupied vacuolar membrane. Microb Pathog, Nov;49(5):273-84.
  • Western Kentucky University
    Undergraduate Research Assistant In Biology Department
    Western Kentucky University Aug 2003 - Dec 2004
    Bowling Green, Ky, Us
    Purified and concentrated Salmonella-specific bacteriophage cultures and identified novel strains using Electron Microscopy (TEM). ------1. M. R. McLaughlin, M. F. Balaa, J. Sims and R. King. (2006) "Isolation of salmonella bacteriophages from swine effluent lagoons." J Environ Qual 35(2): 522-8. https://doi.org/10.2134/jeq2005.0080
  • Western Kentucky University
    Undergraduate Research Assistant In Chemistry Department
    Western Kentucky University Jan 2003 - May 2004
    Bowling Green, Ky, Us
    Analyzed novel compounds synthesized through directed ortho-metalation of Dimethylarylamines using column chromatography and Gas Chromatography/Mass Spectrometry.
  • University Of Louisville
    Summer Research Assistant
    University Of Louisville May 2003 - Aug 2003
    Louisville, Ky, Us
    Extensively used cloning, sequencing, and PCR techniques to identify viral DNA & RNA via novel isolation/detection methods. ------1. Amy L Clem, Jonathan Sims, Sucheta Telang, John W Eaton and Jason Chesney. (2007) "Virus detection and identification using random multiplex (RT)-PCR with 3'-locked random primers." Virol J. Jun 28;4:65. https://doi.org/10.1186/1743-422X-4-65

Jonathan Sims Skills

Cell Culture Cell Pcr Flow Cytometry Immunology Assay Development Dna Biology Molecular Biology Chemistry Western Blotting Mass Spectrometry Sirna Lc Ms Cell Signaling Cell Biology Proteomics Signal Transduction Protein Kinases Autoimmunity Primary Cell Isolation Cancer Research Chemotherapy Cell Based Assays Drug Resistance Facs Analysis Cell Cycle Analysis

Jonathan Sims Education Details

  • University Of Kentucky College Of Medicine
    University Of Kentucky College Of Medicine
    Molecular & Biomedical Pharmacology
  • University Of Kentucky
    University Of Kentucky
    Certificate In Business Administration
  • Western Kentucky University
    Western Kentucky University
    Chemistry
  • Florida College
    Florida College
    General

Frequently Asked Questions about Jonathan Sims

What company does Jonathan Sims work for?

Jonathan Sims works for Eli Lilly And Company

What is Jonathan Sims's role at the current company?

Jonathan Sims's current role is Senior Director at Eli Lilly and Company.

What is Jonathan Sims's email address?

Jonathan Sims's email address is jo****@****ail.com

What is Jonathan Sims's direct phone number?

Jonathan Sims's direct phone number is +185923*****

What schools did Jonathan Sims attend?

Jonathan Sims attended University Of Kentucky College Of Medicine, University Of Kentucky, Western Kentucky University, Florida College.

What are some of Jonathan Sims's interests?

Jonathan Sims has interest in Exercise, Electronics, Home Improvement, Reading, Collecting.

What skills is Jonathan Sims known for?

Jonathan Sims has skills like Cell Culture, Cell, Pcr, Flow Cytometry, Immunology, Assay Development, Dna, Biology, Molecular Biology, Chemistry, Western Blotting, Mass Spectrometry.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.